Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0001127602-23-015939

EVP, Chief Technology Officer gave up 318 shares (to pay taxes)

  • EVP, Chief Technology Officer acquired 3,364 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lingamneni Anila · EVP, Chief Technology Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-05-15 Grant or award : show line 1 in the form +3,364 20,807 D
2023-05-16 Shares withheld for taxes : show line 2 in the form −318 $89.21 $28,369 20,489 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-15 Grant or award : show line 3 in the form Non-qualified Stock Option (Right to Buy) +7,602 7,602 D
Loading xslF345X04/form4.xml…